Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing

被引：1
|
作者：
Kwon, Janice S. [1 ]
机构：
[1] Univ British Columbia, Dept Obstet & Gynecol, 2775 Laurel St,6th Floor, Vancouver, BC, Canada
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 2D期
关键词：
MUTATIONS; BRCA1; WOMEN;
D O I：
10.6004/jnccn.2023.7331
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Role of Genetic Testing for Screening and Prevention for Ovarian Cancer
    Grann, Victor
    Ashby-Thompson, Maxine
    JAMA INTERNAL MEDICINE, 2013, 173 (02) : 103 - 104
  • [22] Identifying disparities in germline and somatic testing in patients with ovarian cancer in a university health system
    Kamath, P. N.
    Schlumbrecht, M. P.
    George, S.
    Slomovitz, B. M.
    Koru-Sengul, T.
    Miao, F.
    Driscoll, D.
    Oldak, S.
    Huang, M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 134 - 134
  • [23] Somatic testing lags far behind germline testing in patients with epithelial ovarian cancer: A missed opportunity
    Ostiller, Kayla
    Marjon, Nicole
    Block, Lawrence
    Powell, Bethan
    Garcia, Christine
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S236 - S237
  • [24] Retrospective analysis of oncologic outcomes by germline and somatic genetic status in patients with ovarian cancer
    Levine, Monica
    Senter, Leigha
    Haight, Paulina
    Wagner, Vincent
    O'Malley, David
    Backes, Floor
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S263 - S264
  • [25] Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?
    Liu, Ying L.
    Sia, Tiffany Y.
    Varice, Nancy
    Wu, Michelle
    Byrne, Maureen
    Khurram, Aliya
    Kemel, Yelena
    Sheehan, Margaret
    Galle, Jesse
    Sabbatini, Paul
    Brown, Carol
    Roche, Kara Long
    Chi, Dennis
    Solit, David B.
    Mueller, Jennifer
    Stadler, Zsofia K.
    Hamilton, Jada G.
    Aghajanian, Carol
    Abu-Rustum, Nadeem R.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [26] Somatic tumor testing implications for Lynch syndrome germline genetic testing
    Barrus, Kathleen
    Purington, Natasha
    Chun, Nicolette
    Ladabaum, Uri
    Ford, James M.
    CANCER GENETICS, 2022, 264 : 16 - 22
  • [27] Same day service: A genetic testing station model to improve germline genetic testing in patients with ovarian cancer
    Marjon, Nicole
    Guerra, Rosa
    Freeman, Alexandra
    Mak, Julie
    Cheung, Stephanie
    Gordon, Kelly
    Blanco, Amie
    Ueda, Stefanie
    Chen, Lee-may
    GYNECOLOGIC ONCOLOGY, 2023, 177 : 53 - 59
  • [28] Integrated analysis of germline and somatic variants in ovarian cancer
    Krishna L. Kanchi
    Kimberly J. Johnson
    Charles Lu
    Michael D. McLellan
    Mark D. M. Leiserson
    Michael C. Wendl
    Qunyuan Zhang
    Daniel C. Koboldt
    Mingchao Xie
    Cyriac Kandoth
    Joshua F. McMichael
    Matthew A. Wyczalkowski
    David E. Larson
    Heather K. Schmidt
    Christopher A. Miller
    Robert S. Fulton
    Paul T. Spellman
    Elaine R. Mardis
    Todd E. Druley
    Timothy A. Graubert
    Paul J. Goodfellow
    Benjamin J. Raphael
    Richard K. Wilson
    Li Ding
    Nature Communications, 5
  • [29] Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake
    Byrne, Maureen
    Sia, Tiffany Y.
    Fong, Christopher
    Khurram, Aliya
    Waters, Michele
    Kemel, Yelena M.
    Zhou, Qin
    Ranganathan, Megha
    Roche, Kara Long
    Chi, Dennis S.
    Saban, Sally
    Wu, Michelle
    Varice, Nancy
    Hamilton, Jada G.
    Carrot-Zhang, Jian
    Abu-Rustum, Nadeem R.
    Iasonos, Alexia
    Ellenson, Lora H.
    Mandelker, Diana
    Weigelt, Britta
    Brown, Carol L.
    Aghajanian, Carol
    Stadler, Zso fi
    Liu, Ying L.
    GYNECOLOGIC ONCOLOGY, 2024, 183 : 126 - 132
  • [30] The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?
    Liu, Ying L.
    Stadler, Zsofia K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (07): : 871 - 878
12345